References
- Alexopoulos, G. S., Jeste, D. V., Chung, H., Carpenter, D., Ross, R., & Docherty, J. P. (2005). The expert consensus guideline series Treatment of dementia and its behavioral disturbances. Introduction: Methods, commentary, and summary. Postgraduate Medicine, Spec No: 6–22.
- Azermai, M., Petrovic, M., Elseviers, M. M., Bourgeois, J., Van Bortel, L. M., & Vander Stichele, R. H. (2012). Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Research Reviews, 11, 78–86.
- Banerjee, S., Hellier, J., Dewey, M., Romeo, R., Ballard, C., Baldwin, R., … Burns, A. (2011). Sertraline or Mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet, 30(403), 403–411.
- Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L.…, (2001). Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56(9), 1154–1166.
- Enache, D., Winblad, B., & Aarsland, D. (2011). Depression in dementia: Epidemiology, mechanisms, and treatment. Current Opinion in Psychiatry, 24, 461–472.
- Gellis, Z. D., McClive-Reed, K. P., & Brown, E. L. (2009). Treatments for depression in older persons with dementia. Clinical Care and Aging, 17, 29–36.
- Hogan, D. B., Bailey, P., Black, S., Carswell, A., Chertkow, H., Clarke, B., & Thorpe, L. (2008). Diagnosis and treatment of dementia: Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. Canadian Medical Association Journal, 179(10), 1019–1026.
- Orgeta, V., Qazi, A., Spector, A. E., & Orrell, M. (2014). Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database of Systematic Reviews, 1. Art. No.: CD009125. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009125.pub2/pdf. doi:10.1002/14651858.CD009125.pub2.
- Palmer, K., Berger, A. K., Monastero, R., Winblad, B., Backman, L., & Fratiglioni, L. (2007). Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology, 68(19), 1596–1602.
- Salzman. C., Jeste, D. V., Meyer, R. E., Cohen-Mansfield, J., Cummings, J., Grossberg, G. T., & Zubenko, G. S. (2008). Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. Journal of Clinical Psychiatry 2008;69:889–98.
- Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Caselli, R. J., & Panza, F. (2007). Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging. Dementia and Geriatric Cognitive Disorders, 24(1), 55–64.
- Van Der Hooft, C. S., Schoofs, M. W. C. J., Ziere, G., Hofman, A., Pols, H. A. P., Sturkenboom, M. C. J. M., & Stricker, B. H. (2008). Inappropriate benzodiazepine use in older adults and the risk of fracture. British Journal of Clinical Pharmacology 2008;66:276–82.
- Visser, P. J., Scheltens, P., & Verhey, F. R. (2005). Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? Journal of Neurology, Neurosurgery, and Psychiatry, 76, 1348–1354.